190 related articles for article (PubMed ID: 33118117)
21. A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers.
Lee J; Kim S; Kim P; Liu X; Lee T; Kim KM; Do IG; Park JO; Park SH; Jang J; Hoe N; Harvie G; Kuller A; Jain A; Meyer G; Leesman G; Park YS; Choi MG; Sohn TS; Bae JM; Lim HY; Singh S; Kang WK
PLoS One; 2013; 8(1):e54644. PubMed ID: 23372746
[TBL] [Abstract][Full Text] [Related]
22. [Helicobacter pylori infection and histological types of gastric cancer].
Handa Y; Saitoh T; Kawaguchi M; Misaka R
Nihon Shokakibyo Gakkai Zasshi; 1999 Jun; 96(6):634-43. PubMed ID: 10396934
[TBL] [Abstract][Full Text] [Related]
23. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
24. The Role of E-cadherin in Helicobacter pylori-Related Gastric Diseases.
Zhang Y; Li D; Dai Y; Li R; Gao Y; Hu L
Curr Drug Metab; 2019; 20(1):23-28. PubMed ID: 29938616
[TBL] [Abstract][Full Text] [Related]
25. Density of Helicobacter pylori infection evaluated semiquantitatively in gastric cancer.
Tokunaga Y; Shirahase H; Hoppou T; Kitaoka A; Tokuka A; Ohsumi K
J Clin Gastroenterol; 2000 Oct; 31(3):217-21. PubMed ID: 11034000
[TBL] [Abstract][Full Text] [Related]
26. Expression profile of intestinal stem cell and cancer stem cell markers in gastric cancers with submucosal invasion.
Kim HS; Song HJ; Kim HU; Jeong IH; Koh HM; Shin JH; Jang BG
Pathol Res Pract; 2021 Feb; 218():153336. PubMed ID: 33450435
[TBL] [Abstract][Full Text] [Related]
27. Diffuse submucosal cysts of the stomach associated with gastric cancer: contribution of Helicobacter pylori infections.
Nakao A; Sato S; Nabeyama A; Sakagami K; Isozaki H; Tanaka N
Anticancer Res; 2001; 21(5):3711-5. PubMed ID: 11848549
[TBL] [Abstract][Full Text] [Related]
28. [Helicobacter pylori and the progression of gastric cancer: a 10-year cohort study].
Ma JL; Zhang L; Pan KF; Liu WD; Feng GS; You WC
Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2758-61. PubMed ID: 16324316
[TBL] [Abstract][Full Text] [Related]
29. Current Status on Stem Cells and Cancers of the Gastric Epithelium.
Hoffmann W
Int J Mol Sci; 2015 Aug; 16(8):19153-69. PubMed ID: 26287172
[TBL] [Abstract][Full Text] [Related]
30. Metaplasia in the Stomach-Precursor of Gastric Cancer?
Kinoshita H; Hayakawa Y; Koike K
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28953255
[TBL] [Abstract][Full Text] [Related]
31. Endoscopic and histological features of gastric cancers after successful Helicobacter pylori eradication therapy.
Saka A; Yagi K; Nimura S
Gastric Cancer; 2016 Apr; 19(2):524-530. PubMed ID: 25752268
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow-derived mesenchymal stem cells promote Helicobacter pylori-associated gastric cancer progression by secreting thrombospondin-2.
Shi H; Qi C; Meng L; Yao H; Jiang C; Fan M; Zhang Q; Hou X; Lin R
Cell Prolif; 2021 Oct; 54(10):e13114. PubMed ID: 34435402
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of white gastric crypt openings observed via magnifying endoscopy.
Kawamura M; Sekine H; Abe S; Shibuya D; Kato K; Masuda T
World J Gastroenterol; 2013 Dec; 19(48):9392-8. PubMed ID: 24409067
[TBL] [Abstract][Full Text] [Related]
35. Global DNA hypomethylation is an early event in Helicobacter pylori-related gastric carcinogenesis.
Compare D; Rocco A; Liguori E; D'Armiento FP; Persico G; Masone S; Coppola-Bottazzi E; Suriani R; Romano M; Nardone G
J Clin Pathol; 2011 Aug; 64(8):677-82. PubMed ID: 21617174
[TBL] [Abstract][Full Text] [Related]
36. Intratumoral and intertumoral heterogeneity of HER2 immunohistochemical expression in gastric cancer.
Zhang H; Wang Y; Wang Y; Wu D; Lin E; Xia Q
Pathol Res Pract; 2020 Nov; 216(11):153229. PubMed ID: 33010699
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic silencing of microRNA-204 by Helicobacter pylori augments the NF-κB signaling pathway in gastric cancer development and progression.
Chen P; Guo H; Wu X; Li J; Duan X; Ba Q; Wang H
Carcinogenesis; 2020 Jun; 41(4):430-441. PubMed ID: 31873718
[TBL] [Abstract][Full Text] [Related]
38. Comparison between Resectable Helicobacter pylori-Negative and -Positive Gastric Cancers.
Kim HJ; Kim N; Yoon H; Choi YJ; Lee JY; Kwon YH; Yoon K; Jo HJ; Shin CM; Park YS; Park DJ; Kim HH; Lee HS; Lee DH
Gut Liver; 2016 Mar; 10(2):212-9. PubMed ID: 26087794
[TBL] [Abstract][Full Text] [Related]
39.
Liu LP; Sheng XP; Shuai TK; Zhao YX; Li B; Li YM
World J Gastroenterol; 2018 Oct; 24(40):4565-4577. PubMed ID: 30386106
[TBL] [Abstract][Full Text] [Related]
40. Ghrelin in diseases of the gastric mucosa associated with Helicobacter pylori infection.
Zub-Pokrowiecka A; Rembiasz K; Konturek SJ; Budzynski A; Konturek PC; Budzynski P
Med Sci Monit; 2010 Oct; 16(10):CR493-500. PubMed ID: 20885354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
